Home Markets Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats

Novo Nordisk cuts forecasts, shares rise ahead of FDA ban on Wegovy copycats

May 07, 2025 comments off

Original source: https://www.investing.com/news/stock-market-news/obesity-drugmaker-novo-nordisk-cuts-2025-outlook-posts-q1-profit-above-forecast-4027000

You May Also Like

Brazil stocks lower at close of trade; Bovespa down 0.09%

Canada stocks higher at close of trade; S&P/TSX Composite up 0.75%

Hedge Fund Millennium in talks with Goldman’s Petershill Partners on stake sale, FT reports

Low-cost carriers hit hardest by US travel demand slump

Volvo Cars recalls over 400,000 US vehicles over rearview camera issue, NHTSA says

CrowdStrike to lay off 5% of staff, reaffirms forecasts